Azusa Nagao: Why Is von Willebrand Disease Still Being Missed in Japan?
Azusa Nagao, Lecturer at Department of Hematology-Oncology, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia, adding:
“I am pleased to share that our article, ‘Exploratory Claims-Based Assessment of Diagnosed and Potentially Undiagnosed von Willebrand Disease in Japan,’ has been published in Haemophilia
Using a large Japanese health insurance claims database, we found that the estimated number of diagnosed von Willebrand disease (VWD) cases in Japan in 2024 was only 1,232.
This number is strikingly low for the most common inherited bleeding disorder.
Even more importantly, among patients with an observable first confirmed VWD diagnosis, 92.2% had already visited healthcare settings with preceding bleeding-related or haematological diagnoses before receiving a confirmed VWD diagnosis.
The median interval from the first such diagnosis to confirmed VWD diagnosis was 33.7 months.
In other words, many patients had already entered the healthcare system with potentially relevant symptoms, yet it still took nearly three years to reach a VWD diagnosis.
Our model also estimated an additional 1,059 potentially undiagnosed cases among individuals with selected ‘VWD differential’ diagnoses, further highlighting the possibility of substantial under-recognition.
These findings underscore the urgent need to improve awareness of VWD, not only among haematologists but also across gynaecology, otolaryngology, paediatrics, dentistry, and general internal medicine, where patients with mucocutaneous bleeding symptoms may first present.
I sincerely thank my co-authors and collaborators for their contributions to this work!”
Title: Exploratory Claims-Based Assessment of Diagnosed and Potentially Undiagnosed von Willebrand Disease in Japan
Authors: Fumikazu Shimamura, Kosuke Iwasaki
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC
-
Oct 10, 2026, 00:34Raphaëlle Dodart: Discussing the Mechanisms of Menstrual Hemostasis
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia